Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Whitfield

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Plos One|July 29, 2015
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisMichael G Whitfield, Heidi M Soeters, Robin M Warren, et al.
The Journal of Infectious Diseases|July 1, 1985
Serological and virological evidence of a Hantaan virus-related enzootic in the United StatesT F Tsai, S P Bauer, D R Sasso, et al.
European Journal of Cell Biology|November 1, 1985
A monoclonal antibody identifies a 215 000-dalton nuclear envelope protein restricted to certain cell typesG Brown, B M Turner, C J Morris, et al.
Journal of Clinical Microbiology|November 10, 2021
Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosisMichael G Whitfield, David M Engelthaler, Christopher Allender, et al.
Tuberculosis (Edinburgh, Scotland)|July 25, 2016
Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosisMichael G Whitfield, Elizabeth M Streicher, Tania Dolby, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 19, 2022
Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature ReviewS Gaito, N Burnet, M Aznar, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisMichael G Whitfield, Robin M Warren, Vanessa Mathys, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2020
Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impactAnnelies Van Rie, Michael G Whitfield, Elise De Vos, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 13, 2023
Proton Beam Therapy in the Reirradiation Setting of Brain and Base of Skull Tumour RecurrencesS Gaito, N G Burnet, M C Aznar, et al.
Jac-Antimicrobial Resistance|March 19, 2024
Prediction of pyrazinamide resistance in <i>Mycobacterium tuberculosis</i> using structure-based machine-learning approachesJoshua J Carter, Timothy M Walker, A Sarah Walker, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Plos One|July 29, 2015
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisMichael G Whitfield, Heidi M Soeters, Robin M Warren, et al.
The Journal of Infectious Diseases|July 1, 1985
Serological and virological evidence of a Hantaan virus-related enzootic in the United StatesT F Tsai, S P Bauer, D R Sasso, et al.
European Journal of Cell Biology|November 1, 1985
A monoclonal antibody identifies a 215 000-dalton nuclear envelope protein restricted to certain cell typesG Brown, B M Turner, C J Morris, et al.
Journal of Clinical Microbiology|November 10, 2021
Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosisMichael G Whitfield, David M Engelthaler, Christopher Allender, et al.
Tuberculosis (Edinburgh, Scotland)|July 25, 2016
Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosisMichael G Whitfield, Elizabeth M Streicher, Tania Dolby, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 19, 2022
Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature ReviewS Gaito, N Burnet, M Aznar, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisMichael G Whitfield, Robin M Warren, Vanessa Mathys, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2020
Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impactAnnelies Van Rie, Michael G Whitfield, Elise De Vos, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 13, 2023
Proton Beam Therapy in the Reirradiation Setting of Brain and Base of Skull Tumour RecurrencesS Gaito, N G Burnet, M C Aznar, et al.
Jac-Antimicrobial Resistance|March 19, 2024
Prediction of pyrazinamide resistance in <i>Mycobacterium tuberculosis</i> using structure-based machine-learning approachesJoshua J Carter, Timothy M Walker, A Sarah Walker, et al.
Pageof 13